| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $452.7M | +89.6% |
| Cost of Revenue | $269.8M | +48.4% |
| Gross Profit | $182.9M | +221.3% |
| R&D Expense | $18.1M | +10.4% |
| SG&A Expense | $71.1M | +25.3% |
| Operating Income | $54.5M | +210.8% |
| Pre-tax Income | $15.1M | +132.9% |
| Income Tax | $1.7M | — |
| Net Income | $13.4M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $220.9M | +58.1% |
| Accounts Receivable | $109.1M | +55.9% |
| Inventory | $47.6M | +21.3% |
| Current Assets | $409.4M | +53.7% |
| Total Assets | $895.1M | +27.3% |
| Current Liabilities | $110.1M | +41.0% |
| Long-term Debt | $95.0M | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $45.5M | +206.9% |
| Capital Expenditures | $86.3M | -50.8% |
| Investing Cash Flow | -$86.3M | +50.8% |
| Financing Cash Flow | $122.0M | +61.7% |
| Free Cash Flow | -$40.7M | +81.3% |
| +129.2% |
| EPS (Basic) | $0.17 | +125.8% |
| EPS (Diluted) | $0.17 | +125.8% |
| Total Liabilities |
| $280.4M |
| +30.4% |
| Stockholders' Equity | $614.7M | +25.9% |